Authors

Empowering Community Cancer Care: Importance of Collaboration

Dr. Gogishvili on the Rationale for the EMPOWER-Lung 3 Trial in NSCLC

The US Oncology Network Highlights Success With Oncology Care Model

Dr Williams on the Evolution of Treatment Approaches in Ovarian Cancer

Dr. Owen on Choosing Between BTK Inhibitors in CLL

Dr Buckingham on the Use of Patient-reported Outcomes to Predict Frailty in Patients With Ovarian Cancer

Key Takeaways and Closing Thoughts on ADCs

Ovarian Cancer Prevention With the Opportunistic Salpingectomy: An Opportunity for Multidisciplinary Collaboration

Designer DNA Therapeutic Wipes Out Cancer Stem Cells, Treats Multiple Myeloma in Mice

How An Interest in Translational Research and Drug Development Helps Evolve Regulatory Practices: With D. Ross Camidge, MD, PhD; and Gideon Blumenthal, MD

Dr. Wu on the Current Utility of Targeted Therapy in CRC

Women in Oncology: Self-Advocacy in a Busy Field

Dr. Kunkler on the 10-Year PRIME 2 Data Examining Post-Surgery Radiation in Breast Cancer

Novel Agents Being Explored in Advanced Biliary Tract Cancers

Challenges of Sequencing and Biomarkers in HCC

Dr. Chao on Key Trials Leading to FDA Approvals in Metastatic NSCLC

Dr. Blum on Potential of CA-125 as a Biomarker for Renal Medullary Carcinoma

Dr Hadoux on the Efficacy of Selpercatinib in RET-Mutant Medullary Thyroid Cancer

MaaT013 Shows Tolerability, Early Efficacy in Refractory Acute GVHD With GI Involvement

Role of Age and Ph Status in Blinatumomab Selection in ALL